Virginie Mariot

7PUBLICATIONS
11CO-AUTHORS
Microelectromechanical systems (MEMS)Molecular targetsMedical devicesGenetically modified animalsMedical virology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Nov 09, 2024
Molecular, Histological, and Functional Changes in Acta1-MCM;FLExDUX4/+ Mice.

Solene Sohn, Sophie Reid, Maximilien Bowen

|Aug 29, 2024
Impact of Disease Severity and Disease-Modifying Therapies on Myostatin Levels in SMA Patients.

Laurane Mackels, Virginie Mariot, Laura Buscemi

|Oct 23, 2021
RIPK3-mediated cell death is involved in DUX4-mediated toxicity in facioscapulohumeral dystrophy.

Virginie Mariot, Romain Joubert, Laura Le Gall

|Dec 30, 2020
Gene Editing Targeting the DUX4 Polyadenylation Signal: A Therapy for FSHD?

Romains Joubert, Virginie Mariot, Marine Charpentier

|Sep 10, 2020
Therapeutic Strategies Targeting DUX4 in FSHD.

Laura Le Gall, Eva Sidlauskaite, Virginie Mariot

|Feb 23, 2020
One-hour universal protocol for mouse genotyping.

Romain Joubert, Virginie Mariot, Julie Dumonceaux

Pageof 2